Lenalidomide Plus Rituximab (R) in Non Follicular NHL
Status:
Unknown status
Trial end date:
2014-10-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether lenalidomide in association with rituximab
is effective in the treatment of patients with indolent non follicular NHL relapsed after
>=2, but less than 4 prior lines of (immuno)chemotherapy.